0000920465-17-000014.txt : 20170106 0000920465-17-000014.hdr.sgml : 20170106 20170106182235 ACCESSION NUMBER: 0000920465-17-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170104 FILED AS OF DATE: 20170106 DATE AS OF CHANGE: 20170106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosen Robert CENTRAL INDEX KEY: 0001555089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 17515422 MAIL ADDRESS: STREET 1: C/O HERON THERAPEUTICS, INC STREET 2: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_148374494293531.xml FORM 4 X0306 4 2017-01-04 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001555089 Rosen Robert C/O LA JOLLA PHARMACEUTICAL COMPANY, 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 19.19 2017-01-04 4 A 0 10000 0 A 2027-01-04 Common Stock 10000.0 10000 D This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock which shall be fully vested and exercisable on January 4, 2018. /s/ Ryan Murr, by power of attorney for Robert Rosen 2017-01-06